420 with CNW – Israeli Researchers Look into Treating Endometriosis Using Cannabis

Gynica, a startup in Israel, has announced that it will conduct research in order to find a new cannabis-based treatment for endometriosis. The startup will use the newly licensed Lumir Lab found within Hebrew University in Jerusalem for this research.

Gynica specializes in providing marijuana-based solutions to the problems affecting the health of women. The lab will focus on medical cannabis research and product development.

Lumir Lab is headed by Lumir Odrej Hanus, one of the leading researchers on cannabinoids in the world. He is an analytical chemist.

Lumir Lab will collaborate with Gynica in this quest for a treatment for endometriosis. Endometriosis is a health condition in which tissues from the lining of the uterus migrate to other parts of the body. The condition causes a lot of pain among its estimated 180 million sufferers across the world.

Current research shows that the reproductive system of females is the second to the brain in terms of having the biggest number of endocannabinoid receptors within the body.

This reality creates an opportunity for cannabis to be used to influence the reproductive system so that uterine lining tissues reduce or stop moving from the uterus to the other internal organs of affected females.

The planned research by Gynica and Lumir Lab is intended to understand how cannabis works to alleviate the symptoms of endometriosis, or even stop the tissues from migrating. The research will also try to find the specific cannabinoids that give the greatest effects in preventing tissue migration or curbing disease recurrence in a way that leaves the ovulation cycle intact.

In the long run, the lab plans to set the standard by which cannabis research and product development is done around the world. Such research will help to address the concerns and reservations within the scientific community regarding cannabis as a treatment for various health conditions.

Currently, many of the cannabis treatments available are largely based on evidence that may not stand up to strict scientific scrutiny. Lumir Lab wants to end all this by bringing clinical analysis, validation and product development to the medical cannabis field. Terpene and cannabinoid profiling will also be done at the lab.

It is this type of research that will make cannabis treatments mainstream since no one will be able to claim that they don’t have any scientific backing behind them. Cannabis industry companies like Net Element (NASDAQ: NETE) and NUGL Inc. (OTC: NUGL) welcome every attempt to gather evidence in support of the different uses of cannabis, including the new efforts launched in Israel by Lumir Lab and Gynica.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Why US Cannabis Companies Are Listing in Canada

Over the coming months and years, more and more U.S. cannabis companies are likely to move north in order to list on stock exchanges in Canada. Many short term and long-term interests are driving this move.

First, Canada recently legalized recreational cannabis years after medical cannabis was permitted in that country. This means that the uniform laws in Canada make that country more attractive (for now) than the U.S. where marijuana companies operating in legal states must constantly look over their shoulders in fear because the federal authorities can take action against them for violating federal laws.

Legitimate cannabis companies in the U.S. constantly feel hunted and moving to Canada can provide some reprieve from the legal issues back home.

The legal issues in the U.S. also make it nearly impossible for cannabis companies to access banking services. Companies conduct all their transactions using cash, and it is hard to find where to keep all that money.

The Canadian environment allows marijuana companies to access some measure of banking services although the bigger banks that have an international presence still keep cannabis businesses at arm’s length due to fears about possible complications in the U.S. and other countries where marijuana is illegal.

Another reason that is driving U.S. marijuana companies across the border to the north is the friendlier listing requirements in Canada when compared to the conditions in the U.S.

For example, only companies that are valued at more than $100 million in publicly held securities can apply to list on the New York Stock Exchange (NYSE). NASDAQ accepts companies whose pre-tax income has been at least $11 million for three years in a row.

Those strict conditions make it hard for marijuana companies to list as soon as they would want in order to access financing to grow and consolidate their positions in the market.

In contrast, the TSX exchange requires a company to have books of accounts that show that the company had at least $300,000 as their pre-tax income the year before they apply to list. Of course there are other conditions, but the income/company valuation differences show how friendlier the stock exchanges in Canada are.

Furthermore, the stock exchanges in the U.S., such as the NYSE, don’t have many purely cannabis businesses listed (partly because of federal laws). Biopharmaceutical companies like GW Pharmaceuticals are the ones one is likely to find on those exchanges. This limits the opportunities for serious market activity for the industry.

Canada has numerous cannabis businesses traded publicly. This provides a vibrant market for companies which want to benefit from the capital that can be got when companies are listed.

As you can see from the factors above, the exodus of U.S. cannabis companies into Canada is likely to continue until conditions back home improve and open that potentially bigger market. Net Element (NASDAQ: NETE), NUGL Inc. (OTC: NUGL) and other companies with interests in the marijuana sector can only hope that the U.S. market opens up sooner.

More from CannabisNewsWire

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Will Utah’s Compromise Deal on Cannabis Work?

Patients, religious leaders, politicians and representatives from some medical cannabis advocacy groups in Utah recently came together to announce that a compromise had been reached to draft a law which would legalize medical cannabis whether the ballot measure (Proposition 2) succeeded during the midterm elections or not.

This compromise deal seems to have been arrived at after Prop 2 polarized the conservative community and threatened to alienate major sections of the community, such as the Mormon Church.

The compromise deal seeks to allow only six “medical cannabis pharmacies” to operate out of which one would be run by the state while the other five would be privately operated. Prop 2 suggested that there would be a medical cannabis dispensary for every 150,000 residents of the state. This would result in more dispensaries than the compromise deal is allowing.

Secondly, the compromise deal wants to prevent people from growing their own cannabis. Prop 2 had indicated that patients could grow their own cannabis and use it in case they couldn’t access medical cannabis at legal dispensaries.

The compromise deal seems to have attained some degree of success in bringing different parties to a middle point on cannabis. For example, the governor of the state expressed his support for the compromise although he was vehemently opposed to Proposition 2.

However, that compromise deal still has critics from both sides of the cannabis divide. For example, opponents of legalization feel the compromise doesn’t go far enough to quell concerns about the possible dangers that may result when medical use cannabis is legalized.

Similarly, advocates of legalization feel that the compromise deal bears the signature of the Latter Day Saints (LDS) church which seems to have approved the legalization but ensured that there are so many restrictions that access will be limited heavily.

Critics of the church say it played the same tactics over LGBTQ issues when it appeared to consent that they deserved to be treated equally, but at the same time created a loophole which allowed members of the church to refuse to preside over LGBTQ marriages due to religious conflict issues. In other words, the Mormon Church said it recognized the LGBTQ members of the community but it would not wed them. What kind of recognition is that?

The compromise deal will be sent to the elected representatives of the people for debate and modification before it is passed into law. In the meantime, both sides are still campaigning heavily either for or against Prop 2. That ballot measure carries huge implications since the outcome of the poll would influence the final provisions of the law enacted to legalize medical cannabis.

Cannabis industry participants like Net Element (NASDAQ: NETE) and NUGL Inc. (OTC: NUGL) can only pray that any decision made puts patients first instead of addressing the interests of different groups that may contradict the interests of the intended beneficiaries of the medical cannabis law.

More from CannabisNewsWire

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Cannabis Stocks Defy Gravity During Market Plunge

CannabisNewsWire Editorial Coverage: In the recent broad stock market sell-off, one sector resisted the market plunge.

Cannabis stocks shined during the market rout.
Global cannabis market is expected to exceed $146 billion by 2025.
Cannabis market analysts predict CAGR of 34.6 percent during next seven years.
Cannabis markets spawn dynamic ancillary businesses.

Multiple marijuana stocks shined in the sea of red during mid-October’s rout, racking up gravity-defying gains. The sizzling sector is sending signals of being uncorrelated with markets that are driven by the imperatives of institutional traders. Being untethered from the vagaries of institutional intentions is most likely advantageous for individuals intent on profiting from the impending cannabis tsunami. Marijuana sector growth has spawned a realm of new dynamic businesses in previously unimagined arenas. Leveraging the immense opportunity, NUGL, Inc. (OTC: NUGL) (NUGL Profile) has developed a first-of-its-kind, cutting-edge search app and comprehensive online directory exclusively for the marijuana industry. Heralded as a global first-mover cannabis connectivity business, NUGL just signed a deal that significantly expands its footprint and reach. The global growth in marijuana has also spurred investments in the sector by such well-known names as Constellation Brands Inc. (NYSE: STZ) and The Scotts Miracle-Gro Company (NYSE: SMG),and has launched marijuana-centric companies such as Terra Tech Corp. (OTCQX: TRTC) and KushCo Holdings, Inc. (OTCQB: KSHB).

To view an infographic of this editorial, click here.

Cannabis Jackpot

Cannabis is understandably generating intense global interest from business interests and investment communities. It’s impossible to ignore a market sector valued at an estimated $7 billion two years ago that’s now projected to exceed $146 billion worldwide by 2025 — a 20-fold increase. The stratospheric growth in the global marijuana market is anticipated to achieve a mind-boggling CAGR of 34.6 percent between 2018 and 2025.

Marijuana markets started gaining global traction in tandem with increased consumer demand for medicinal marijuana utilized for chronic pain and myriad other disorders. Medical marijuana was, in fact, the largest segment of the cannabis sector in 2016, and its value is expected to surpass $100 billion by 2025. The legalization of recreational marijuana use in multiple states and various countries has propelled demand into overdrive. The industry is now on track to bring in $8 billion by the end of this year. The research and development of safer forms of ingesting marijuana such as tinctures, oils, vapes and other edibles are expected to bolster market growth.

Connecting All Things Cannabis

On the cutting edge of the development of organic data analytics in the cannabis industry, NUGL, Inc. (OTC: NUGL) is focused on clearing up consumer confusion about the wide number of product options and becoming an integral asset to the burgeoning sector. While other attempts to connect and codify the spider web of interactions in the legal cannabis community have fallen short of expectations, NUGL expects its first-to-market, best-in-class technology platform to snag the lion’s share of this invaluable new market.

Since cannabis ads are prohibited on most social media networks, including Facebook, NUGL seized the opportunity to create the largest, most robust cannabis business networking platform in the world. The company’s internet-based search apps and online directory are the first ever to deliver global cannabis users networking power with unbiased search results, eliminating paid placement listings and skewed reviews. NUGL’s networking platform employs both business-to-consumer and business-to-business applications, providing the tools the industry needs to connect both pieces of the industry together. This allows all cannabis services, events and brands the ability to network and bring their companies to market.

NUGL’s platform is designed to serve cannabis-related businesses, products, services and users by building a community that meets the needs of each segment. NUGL puts the power of connection and self-promotion back into the hands of cannabis companies, giving them the tools to build a dedicated profile featuring their brands and services. The NUGL cannabis community is experiencing significant growth as dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands are joining daily.

Profiles for Every Community Member

NUGL offers four types of profiles: brands, events, services, and retail. Each of these profiles can connect and interact with each other, allowing an unprecedented level of communication between each segment of the cannabis market. For instance, using the NUGL app, brands can explore and develop their distribution capabilities by connecting with retail locations. Brands can even use the app to market their products, letting stores know about special order discounts, specials, and other marketing information.

When a brand and retail store have inked a distribution deal, the store can benefit by being included on the NUGL store locator. That means that when a user searches for a specific cannabis brand, the retail store appears on a source map, driving consumers to the location.

Cannabis service providers can use NUGL to reach out to everyone on the app, advertising the unique services they provide. For instance, a CPA firm that specializes in the cannabis market can communicate directly with the niche clients it is looking for. And finally, events such concerts or other occasions that either focus on or are open to cannabis users can extend invitations and attract participants.

NUGL’s iOS and Android apps are available in the Apple and the Google Play stores, and the company is intensely consumer focused. Future software development is directed and driven by community feedback. Reinforcing its credo of “for the people, by the people,” NUGL just announced major updates to its app in response to community feedback asking for a more robust mobile application.

In tune with consumer input, NUGL proactively launched major mobile application updates that included, in part, newly redesigned profile pages and updated brand profiles. The company also added new swipe gestures and social media links to profile pages, as well as menu tabs and social share links to profiles. And NUGL simplified search functions with an updated search bar, new filters, improved brand search functionality and redesigned icons.

Multiple Platforms Expand Reach

There’s little doubt about consumer demand for cannabis or the void of platforms to efficiently connect consumers to cannabis-related companies and services. NUGL is rapidly filling that void and expanding at breakneck pace. NUGL’s user sign-ups and mobile app downloads in September eclipsed expectations and surpassed industry standards for comparable tech start-ups.

“We not only saw great returns on our initial spend but also saw the beginning of a viral push. Our next step is to scale our marketing model and watch NUGL grow its user base and app downloads even more,” NUGL CMO Ryan Bartlette stated.

Last month NUGL expanded its footprint and reach through a national joint venture marketing agreement with Nichols Publishing Company. NUGL is adding tens of thousands of print readers and online visitors with cannabis-centered magazines Garden & Greenhouse and Professional Marijuana Grower). Together, the magazines reach a cornucopia of small commercial growers, hobby growers, hydroponic and indoor gardeners, licensed cannabis growing facilities, processors and dispensaries. The magazines complement NUGL Magazine, which covers cannabis industry news and how it affects the cannabis community.

In a dramatic development, NUGL just announced a binding letter of intent to purchase Nichols Publishing Company. In what can be viewed as complete confidence in NUGL’s future, Nichols Publishing agreed to be acquired in exchange for $1 million in NUGL common stock. Nichols Publishing was founded by Robin Nichols more than a decade ago, and its cannabis trade magazines have grown into well-known brands. Nichols will join NUGL following the acquisition and run the publications’ operation under the NUGL name.

With clear intentions to dominate the market for global connectivity as it relates to cannabis consumers and businesses, NUGL’s decision to acquire Nichols Publishing is likely just a beginning as it expands its platforms and global footprint to synergistically support cannabis consumers and cannabis industry growth.

The Epiphany

There’s zero question about the past growth of the marijuana market, and future growth looks even brighter. Although the sector shines even during market sell-offs and marijuana stocks are reaching new highs, some say the sector is top heavy and frothy. If true, from this point forward, nascent ancillary business that feed and support consumers, services and businesses in the cannabis industry may hold much greater upside potential.

Constellation Brands Inc. (NYSE: STZ) just made the largest investment to date in the cannabis space. The company is already a leading international producer and marketer of beer, wine and spirits. With the recent $4 billion investment, Constellation looks to accelerate market position, perhaps create cannabis-infused drinks and expand its portfolio in emerging cannabis markets around the globe.

The Scotts Miracle-Gro Company (NYSE: SMG) is the world’s leading marketer of branded consumer lawn and garden products as well as hydroponic growing products. The company’s wholly owned subsidiary, The Hawthorne Gardening Company, is a leading provider of nutrients, lighting and other materials used in the hydroponic growing segment and now cannabis. The lawn and garden giant invested more than $1 billion in the past few years on a wide variety of companies that produce items connected to cannabis cultivation.

Terra Tech Corp. (OTCQX: TRTC) operates through multiple subsidiary businesses to provide both medical cannabis to patients and premium cannabis to the adult-use market in Nevada and California. The company’s wholly owned subsidiary, Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce. Terra Tech’s MediFarm LLC subsidiaries are focused on medical and adult-use cannabis cultivation and permitting businesses throughout Nevada.

KushCo Holdings, Inc. (OTCQB: KSHB) is the parent company to a diverse group of business units in the cannabis, cannabidiol (CBD) and cannabis-related industries. KushCo’s subsidiaries and brands provide exceptional customer service, product quality, compliancy knowledge and a local presence in serving a diverse customer base. KushCo Holdings’ brands include Kush Supply Company, Kush Energy, Hybrid Creative and Koleto Packaging Solutions.

For more information on NUGL, visit NUGL Inc. (OTC: NUGL)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Analysts Predict the Medical Cannabis Industry Will Out-Earn the Recreational Market

While the world is still marveling at the bold step that Canada took to legalize recreational marijuana and the resources that the recreational market is likely to command with that legalization, analysts are suggesting that the real money is most likely to be made in the medical cannabis arena.

The medical cannabis market is predicted to be worth approximately $50 billion by 2025. This is a huge jump from what the value of the medical cannabis market was in 2017 (just over $8 billion).

The huge potential for the medical marijuana takes on a bigger positive outlook when one considers the rate at which several countries around the world are legalizing the medical use of cannabis.

The UK plans to allow doctors to start prescribing marijuana in November this year. Malaysia is working out how to permit the medical use of cannabis. Denmark and Luxembourg are also taking steps to legalize medical cannabis.

The rate at which the list of countries where medical marijuana is allowed is growing much faster than the rate at which recreational cannabis can be expected to be decriminalized around the world.

The stigma attached to recreational cannabis use is one of the major reasons why one would be well advised to put their money on medical cannabis instead of thinking of investing in the recreational marijuana sector.

It is significant that the FDA approved a marijuana-based drug in June for the treatment of childhood epilepsy. That was the first time that the U.S. agency approved a cannabis-based drug in a country where the federal government still looks at marijuana as a schedule 1 substance (substances with no medical use and a high likelihood of being abused).

Pharmaceutical companies have also been courting Canadian cannabis industries in order to discuss possible partnerships in developing the medical cannabis sector further. For example, the Canadian division of Swiss-based Novartis International AG has reached an understanding with Tilray Inc. to develop cannabis delivery systems and products jointly.

It should be noted that the pharmaceutical industry carefully weighs the prospects in a given sector before making a commitment. This is because lots of resources are usually invested in R & D before a product ever has a chance to reach the market.

The moves by pharmaceutical firms to partner with cannabis companies is therefore an indicator that the long-term prospects for medical cannabis are solid and major investments can be made into the sector. American marijuana companies like NUGL Inc. (OTC: NUGL) and SinglePoint, Inc. (OTCQB: SING) can only pray that the regulatory climate in the U.S. improves quickly so that they aren’t left behind as the medical cannabis industry evolves rapidly.

More from CannabisNewsWire

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Medical Marijuana Users in Illinois Increase by 80 Percent

A report released by the Illinois Department of Public Health shows that the users of medical marijuana in that state have increased by 80 percent so far when compared with the statistics for 2017.

The report shows that most patients using medical cannabis wanted to treat post-traumatic stress disorder (PTSD). More than 4,000 people out of the 46,000 who have used medical marijuana this year used cannabis to treat PTSD.

PTSD was followed by fibromyalgia at 3,400 patients while cancer was close behind at 2,500 patients seeking medical cannabis.

It is also noteworthy that about 75 percent of all patients on medical marijuana were at least 40-years old. This statistic may be correlated to the qualifying conditions for which one can get a recommendation for medical marijuana.

It is predicted that the number of people seeking medical marijuana will rise further for two key reasons.

First, there has been an increase in the number of doctors who get certified to recommend medical marijuana. The number now stands at 3,000 compared to the 2,100 who were available in 2017. Each doctor recommended approximately 25 patients while a few handled about 100 patients each.

This increase means that patients will find it easier to access a doctor who can recommend medical cannabis for their conditions.

Secondly, some regulatory changes will make it easier for people to access medical cannabis. For example, a law was signed by the Governor to allow doctors to prescribe medical marijuana for chronic pain instead of asking patients to take opioid painkillers as was the case before. Additionally, it will be easier to process patient applications since fingerprinting and performing criminal background checks will no longer be part of the process through which medical marijuana applicants are screened.

However, some medical experts are warning that the use of medical marijuana may create cases of substance abuse. This fear arises because some of the medical cannabis dispensaries have products which are about 90 percent THC. THC is the psychoactive ingredient of marijuana responsible for the high experienced by users.

The addiction experts are also concerned about the quantities that patients can buy. In their view, the current limit is high and can permit a patient to consume the cannabis product on a daily basis. Addiction can easily arise when that happens.

You can be certain that companies like NUGL Inc. (OTC: NUGL) and Pacific Software, Inc. (OTC: PFSF) are crunching the numbers coming from Illinois in order to see what direction the medical marijuana industry will take in the coming years.

More from CannabisNewsWire

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Why Legalizing Recreational Cannabis in New Jersey May Be a Game Changer

Medical cannabis has been legal in New Jersey since 2010. However, there are moves to expand the medical marijuana program and also decriminalize recreational pot in the state possibly by the end of this year or early next year. Industry watchers are suggesting that the legalization of recreational cannabis in New Jersey would be a game changer for the entire industry for a number of reasons.

First, the long history of cannabis prohibition in the state makes New Jersey one of the places with the largest number of people incarcerated for cannabis-related issues. New Jersey therefore has a big social wrong to address and the decriminalization of recreational cannabis could provide a template for the other states with similar issues to copy from.

This copying is likely to be similar to the way many states are copying the way California has regulated the home delivery of medical marijuana. “It has worked there, so there is no reason why it won’t work here” is a statement legislators and regulators are likely to use a lot when referring to the precedents set in New Jersey.

Secondly, New Jersey enforces some of the highest property rates in the U.S. This is likely to be factored into any legal regime designed to regulate the cannabis industry. The economic boom that could arise from the opportunities within the cannabis industry can encourage other states to borrow a leaf from New Jersey’s journey and trigger their own economic revival.

The third reason why New Jersey is likely to be a game changer for the cannabis industry is that it has the backing of the elected leaders of the community at different levels. For example, the governor, the senate president as well as the top honcho at the department of health are all eager to see cannabis legislation enacted as soon as possible.

This support for cannabis legislation is likely to produce a framework that will be a reference point for the other states which are also moving towards marijuana decriminalization.

The fourth reason is that New Jersey has a first-class healthcare system, world-class bio-tech and some of the top medical research institutions. These unique advantages mean that there will be no shortage of relevant research for product development or law reform. Consequently, New Jersey may be to the cannabis industry what Silicon Valley is to the tech industry.

The affluent population also makes it an exciting market for companies that wish to create products and test how the different market segments would respond to those innovations. Medical Cannabis Payment Solutions (OTC: REFG) and NUGL Inc. (OTC: NUGL) can only dream of what their businesses would be like if all states had the characteristics of New Jersey.

For now, the country can only wait to see what sort of regulatory framework will be instituted when the cannabis bill is debated, modified and finally passed.

More from CannabisNewsWire

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – Washington D.C. Sees Spike of Synthetic Marijuana Overdoses

It seems the synthetic marijuana overdoses that had the authorities in Washington, D.C worried in July have resurfaced after a lull. In one 24-hour period alone, first responders were called to assist dozens of people who exhibited severe signs of distress from K2 or Spice, a known synthetic form of cannabis.

Even more distressing is the fact that students witnessed some of the victims being helped on the street as the students were strolling about during their break. This was near Mundo Verde Bilingual Public School. The authorities responded by imposing restrictions on how far students could go during their break.

Some of the symptoms exhibited by the people overdosing on K2 are particularly worrying. The known chemicals from which K2 are made don’t usually cause users to bleed in the way that some of the D.C. victims have been seen to bleed.

One possible explanation for that bleeding may have been found after toxicological tests revealed that the synthetic marijuana was laced with the chemical brodifacoum. This is a substance that is used to make rat poison and other pesticides.

The chemical stops vitamin K from doing its work in the blood of the organisms that ingest it. Consequently, vital processes, such as blood clotting, will be affected, and bleeding will result.

The consumers, especially low-income people, don’t seem to be bothered by the risk of K2 and other synthetic forms of marijuana. To them, all that seems matters is that they get a high at an affordable cost.

Authorities say that they have been compelled to play cat and mouse games with the people who make or distribute these synthetic forms of marijuana. This is because the chemicals used are often permitted chemicals, except that the formulas used aren’t approved. Banning one chemical found to be harmful only spurs the makers of the product to switch to another unknown product.

Furthermore, distributors often escape regulatory scrutiny by labeling the synthetic marijuana as “not for human consumption”. The CDC, DEA and other agencies are therefore often chasing a ghost that is hard to pin down.

However, the authorities are now determined to hunt down and stamp out these dangerous products whose overdoses have reached crisis level and are spreading to various parts of the country.

The big question on many people’s minds is that if this is happening in Washington, D.C., where marijuana is legal, can something be done to make the legal product more affordable for those with limited means? You can bet your last dollar that Marijuana Company of America Inc. (OTC: MCOA) and NUGL Inc. (OTC: NUGL) are praying that these products be wiped out so that the industry doesn’t get a bad reputation at this early stage.

More from CannabisNewsWire

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net